← Back to news

Markets

Mesoblast Limited (MESO), One of the Best Long-Term ASX Stocks To Buy Right Now; See Why

Y

Citi Remains Confident in Life360 (LIF)’s Long-Term Potential with Raised PT of $68.3

Y

Woodside Energy (WDS) Looks to Improve Analyst Sentiment With New Non-Operated Oil Discovery at Bandit-1 Site

Y

National Bank Downgrades Newmont (NEM) to “Sector Perform” Amid Rising Costs Tied to Higher Diesel Prices

Y

JPMorgan Initiates ResMed (RMD) With “Overweight” Rating and A$37.6 PT

Y

Truist Cuts PT on Amcor plc (AMCR) to $50 Amid Higher Energy and Freight Costs

Y

Alcoa (AA) Well-Positioned In A Highly Volatile Mining Backdrop, According to Morgan Stanley

Y

Strong Analyst Sentiment on Block (XYZ) As Company Looks to Streamline and Differentiate Its Fintech Platform

Y

Intel Stock Has Added More Than $137 Billion in Value Since March 30. Here's What Happens Next.

Y

Analyst sends bold stock market message as S&P 500 hits new highs

Y

Forget The Chip Boom: Wall Street's 'Ultimate Contrarian Trade' Favors Software For 2026

Y

People Say Their Power Bills Are Spiking Even Though They Haven't Changed Their Habits. 'I'm Kicking Myself That I Didn't Get Solar Years Ago'

Y

Michael Saylor’s Latest Post Has the Market Looking for Strategy’s Next Bitcoin Buy

Y

Prediction: The Biggest Winners of 2026 Are These 5 AI Stocks Nobody's Paying Attention to Right Now

Y

Deloitte just axed $50K IVF funds, halved parental leave and cut PTO — and your employer could be next

Y

This Stock Will Be More Profitable Than Amazon and Meta by 2027

Y

Here's the 1 thing to Watch When Lemonade Releases Earnings on April 29

Y

Fidelity’s Most Underrated ETF Has Been Right About Bonds Longer Than Most Analysts

Y

The Market Pundits Got It Wrong Again: What That Should Tell Every Investor

Y

Home Depot salaries: From sales rep to CEO

Y

The Smartest Growth Stocks to Buy With $1,000 Before the Nasdaq Heads Higher

Y

The 10 Public Companies With the Biggest Bitcoin Portfolios

Y

Will Nvidia Be Worth $6 Trillion a Year From Now? Wall Street Has a Clear Answer.

Y

Why Are Bitcoin, XRP, and Solana All Rallying? 3 Reasons the Crypto Market Is Up This Week

Y

Wells Fargo says gold could nearly double to $8,000 an ounce — even after its worst monthly drop in a decade

Y

Should You Buy the Netflix Dip?

Y

Indeed CEO says retiring boomers are a bigger threat to the economy than AI — and the worker shortage is already here

Y

Graham Stephan Says 'Nothing Makes Sense Anymore' As S&P 500 And Nasdaq Break Records. Here's His Strategy For Retirement

Y

PFXF’s 6.6% Yield Still Looks Safe as it Skips Banking Sector’s Biggest Dividend Risks

Y

The Trade Desk CEO Just Put $150 Million of His Own Money Into the Stock. Here's Why That's a Signal You Shouldn't Ignore.

Y

Software stock dogs have joined market rally. There's a classic investing lesson in the rebound

F

Retiring at 62 With $1.8 Million Means Covering a $47,000 Healthcare Gap Before Medicare Kicks In

Y

This Overlooked Vanguard ETF Is Quietly Outperforming Its Rivals

Y

Could This Healthcare Stock Help Make You Rich Over the Next Decade?

Y

Should You Buy the Vanguard S&P 500 ETF With the Stock Market At a Fresh Record High? The Answer Might Surprise You.

Y

AI Traffic to US Retailers Jumps 393% in Q1 as Agentic Shoppers Outspend Humans

Y

TechCrunch Mobility: Uber enters its assetmaxxing era

Y

Cheap batteries are taking over the world’s power grids

Y

In 10 Years, Will You Wish You'd Bought Plug Power Stock Right Now?

Y

Are You a Rich Household? Here's The Income It Takes To Be Poor, Middle Class, Or Wealthy

Y

Telix Pharmaceuticals (TLX) Doses First Patient in Phase 3 Trial for Brain Cancer Therapy

Y

Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy

Y

Calumet (CLMT) Closes $150M Private Placement of Senior Notes

Y

FDA Accepts Ultragenyx (RARE) BLA for Sanfilippo Syndrome Gene Therapy UX111

Y

Sigma Lithium (SGML) Secures $100M Bank Guarantee for Expansion Financing

Y

GitLab (GTLB): 10 Overlooked Growth Stocks to Buy Now

Y

Here is Why Travere (TVTX) is an Overlooked Growth Stocks to Buy Now

Y

Is Legend Biotech (LEGN) One of the Overlooked Growth Stocks to Buy Now?

Y

Nike Looks Cheap, But You Have to Believe the Shoemaker can "Just Do It"

Y

An Aehr Test Systems Director Sold 8,000 Shares. Here's What That Means for Investors.

Y